Substandard Cancer Drugs in India: What Patients Need to Know

 

A recent investigation by the Bureau of Investigative Journalism, reported in The Hindu, has revealed that many chemotherapy drugs exported from India are failing basic quality tests.

For a country that is both a global pharmaceutical hub and home to over 1.5 million new cancer cases annually, this revelation raises serious concerns—not just about regulatory oversight, but about patient safety.

These are some of the chemotherapy drugs found to have failed quality checks:

Drug Name	Used For	Mechanism	Key Side Effects
Cisplatin	Testicular, ovarian, lung, bladder cancers	Binds to DNA, halts cell division	Kidney damage, immune suppression, hearing loss
Oxaliplatin	Advanced colorectal cancer	Similar to cisplatin	Nerve pain, nausea, vomiting
Cyclophosphamide	Leukemia, breast cancer, sarcoma	Damages cancer DNA	Bladder inflammation, infection risk
Doxorubicin	Breast cancer, leukemia, lymphoma	Interferes with DNA replication	Heart toxicity, skin problems, hair loss
Methotrexate	Tumors, leukemia, lymphoma	Blocks DNA synthesis	High-dose toxicity, mitigated by leucovorin
Leucovorin	With methotrexate to reduce toxicity	Vitamin B9 that protects healthy cells	Safe; balances methotrexate effects

These drugs are essential to many cancer regimens. Any compromise in their quality can severely impact treatment outcomes and patient survival.

Understanding Cancer Treatment in India

India is witnessing a growing burden of cancer. With more than 1.5 million new cases diagnosed annually, access to safe, affordable, and effective treatment is paramount.

Treatment Type	Purpose
Surgery	Physical removal of tumors or affected tissue
Radiation Therapy	Use of high-energy rays to kill or shrink cancer cells
Chemotherapy	Use of anti-cancer drugs to target fast-dividing cells
Immunotherapy	Boosting the body’s natural defense mechanisms
Targeted Therapy	Focused action on specific cancer cell proteins or genes
Bone Marrow Transplant	Replacement of damaged or destroyed bone marrow
Palliative Care	Relieves symptoms and improves quality of life in late stages

 

Government Programs Supporting Cancer Care

Scheme	Key Focus
Ayushman Bharat–PMJAY	Free cancer treatment for poor and vulnerable families
National Programme for Prevention and Control of Cancer (NPCDCS)	Screening, awareness, and early detection
Tertiary Cancer Care Centres (TCCC)	Upgrading hospitals with cancer care infrastructure
Health Minister’s Cancer Patient Fund	Financial aid for critical cases
State Insurance Schemes (e.g., Arogyasri)	Additional support at the state level

 

India is investing in innovation and technology to improve outcomes and accessibility:

• Digital Cancer Registry to track data and trends across regions
• AI-powered diagnostics for faster, more accurate detection
• National Cancer Grid (NCG) connecting over 300 cancer hospitals for consistent standards
• Push for indigenous drug production to cut costs and ensure supply stability

Why Drug Quality Is a Matter of Life and Death

When chemotherapy drugs are substandard, it directly compromises the effectiveness of treatment and increases the risk of resistance and relapse. For patients and families already under immense emotional and financial pressure, this becomes an unacceptable burden.

As India continues to position itself as the pharmacy of the world, maintaining drug quality and ethical manufacturing standards must be treated as a national priority.

Conclusion: A Call for Ethical, Patient-Centric Reform

Behind every statistic is a patient. A family. A hope.

It is not enough to build infrastructure or run programs—we must ensure that the tools we use to fight cancer are reliable and safe. This means stricter regulations, better inspections, transparent reporting, and a culture of accountability in both public and private healthcare sectors.

India’s fight against cancer can succeed—but only if quality becomes non-negotiable.